OneDigital Investment Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

OneDigital Investment Advisors’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$320K	Sell	9,325 -439	-4%	-$15K	﹤0.01%	1153
2025 Q4	$322K	Buy	+9,764	New	+$304K	﹤0.01%	1174
2023 Q4	–	Sell	-8,054	Closed	-$206K	–	1117
2023 Q3	$206K	Sell	8,054 -225	-3%	-$5.95K	﹤0.01%	930
2023 Q2	$217K	Sell	8,279 -117	-1%	-$3.09K	﹤0.01%	932
2023 Q1	$219K	Sell	8,396 -485	-5%	-$13K	0.01%	883
2022 Q4	$244K	Buy	+8,881	New	+$236K	0.01%	722

Other funds holding FTXH

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

OneDigital Investment Advisors's FTXH Position: Q1 2026 in Review

OneDigital Investment Advisors reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 4.5% in Q1 2026, selling an estimated $15K and leaving 9,325 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #1153.

OneDigital Investment Advisors first reported a position in FTXH in Q4 2022 and has held it in 6 quarters since. The position peaked at $322K in Q4 2025. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

OneDigital Investment Advisors held 9,325 shares of First Trust Nasdaq Pharmaceuticals ETF worth $320K as of Q1 2026.
OneDigital Investment Advisors sold 439 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $15K.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q1 2026, its #1153 holding.
OneDigital Investment Advisors first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2022 and has held it in 6 quarters since.
OneDigital Investment Advisors's First Trust Nasdaq Pharmaceuticals ETF position peaked at $322K in Q4 2025.
32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on OneDigital Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.